<DOC>
	<DOCNO>NCT03011515</DOCNO>
	<brief_summary>The purpose study validate diagnostic accuracy novel host-response base diagnostic tool differentiate bacterial viral etiology adult patient age 18 year old clinical suspicion lower respiratory tract infection ( LRTI )</brief_summary>
	<brief_title>Evaluating Host-response Based Diagnostic Distinguishing Between Bacterial Viral Etiology Patients With Lower Respiratory Tract Infection ( LRTI )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<criteria>Patients age 18 year old agree ( legal guardian agree ) sign inform consent eligible inclusion . The LRTI cohort also fulfill follow criterion : Peak fever ≥37.8°C ( 100°F ) ( AND ) Symptoms duration ≤7 day ( AND ) Clinical suspicion LRTI include pneumonia Another episode acute infection last 3 week Congenital immune deficiency ( CID ) A proven suspect human immunodeficiency virus ( HIV ) 1 , hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) infection Active malignancy Pregnancy Current treatment immunesuppressive immunemodulating therapy include without limitation : High dose steroid &gt; 1 mg/kg/day prednisone equivalent Monoclonal antibody administration Intravenous immunoglobulin ( IVIG ) Cyclosporine Granulocyte/Monocyte colony stimulate factor ( G/GMCSF ) AntiTumor Necrosis Factor ( TNF ) agent Interferon ( kind ) Other severe illness affect life expectancy quality life : Moderate severe psychomotor retardation Moderate severe congenital metabolic disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>